pharmaceuticals: be more expensive in us

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents industry
Weight: 0.48
, environment
Weight: 0.28
Siblings banking industry
Weight: 0.32
, automobile industry
Weight: 0.32
, chemicals
Weight: 0.31
, electronics
Weight: 0.31
, semiconductor
Weight: 0.30

Related properties

Property Similarity
be more expensive in us 1.00
be expensive in us 0.97
be important for us 0.87
be important to us 0.86
is expensive 0.85
be significant for us 0.82
be more expensive in europe 0.82
be more important than economy 0.81
be expensive in states 0.80
be more expensive in uk 0.79

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.50
Rule weight: 0.66
Evidence weight: 0.87
Similarity weight: 0.87
Evidence: 0.81
Plausible(industry, be important for us)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)
0.50
Rule weight: 0.66
Evidence weight: 0.86
Similarity weight: 0.87
Evidence: 0.80
Plausible(environment, be important for us)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)
0.45
Rule weight: 0.66
Evidence weight: 0.82
Similarity weight: 0.82
Evidence: 0.73
Plausible(industry, be significant for us)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)
0.34
Rule weight: 0.66
Evidence weight: 0.64
Similarity weight: 0.81
Evidence: 0.48
Plausible(environment, be more important than economy)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.81
Similarity weight: 0.81
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.48
¬ Plausible(environment, be more important than economy)
0.06
Rule weight: 0.09
Evidence weight: 0.69
Similarity weight: 0.87
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.80
¬ Plausible(environment, be important for us)
0.06
Rule weight: 0.09
Evidence weight: 0.68
Similarity weight: 0.87
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.81
¬ Plausible(industry, be important for us)
0.05
Rule weight: 0.09
Evidence weight: 0.71
Similarity weight: 0.82
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.73
¬ Plausible(industry, be significant for us)

Remarkability exclusitivity betweem a parent and a child

0.33
Rule weight: 0.58
Evidence weight: 0.67
Similarity weight: 0.87
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.66
¬ Remarkable(environment, be important for us)
0.31
Rule weight: 0.58
Evidence weight: 0.61
Similarity weight: 0.87
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.77
¬ Remarkable(industry, be important for us)
0.28
Rule weight: 0.58
Evidence weight: 0.59
Similarity weight: 0.82
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.81
¬ Remarkable(industry, be significant for us)
0.25
Rule weight: 0.58
Evidence weight: 0.53
Similarity weight: 0.81
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.92
¬ Remarkable(environment, be more important than economy)

Remarkability exclusitivity between siblings

0.11
Rule weight: 0.13
Evidence weight: 0.97
Similarity weight: 0.82
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.06
¬ Remarkable(electronics, be more expensive in europe)
0.10
Rule weight: 0.13
Evidence weight: 0.96
Similarity weight: 0.79
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.09
¬ Remarkable(electronics, be more expensive in uk)
0.09
Rule weight: 0.13
Evidence weight: 0.76
Similarity weight: 0.85
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.47
¬ Remarkable(semiconductor, is expensive)
0.07
Rule weight: 0.13
Evidence weight: 0.59
Similarity weight: 0.86
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.82
¬ Remarkable(electronics, be important to us)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.87
Evidence: 0.81
Plausible(industry, be important for us)
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.61
¬ Plausible(pharmaceuticals, be more expensive in us)
0.34
Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.87
Evidence: 0.80
Plausible(environment, be important for us)
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.61
¬ Plausible(pharmaceuticals, be more expensive in us)
0.32
Rule weight: 0.42
Evidence weight: 0.92
Similarity weight: 0.82
Evidence: 0.73
Plausible(industry, be significant for us)
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.61
¬ Plausible(pharmaceuticals, be more expensive in us)
0.29
Rule weight: 0.42
Evidence weight: 0.84
Similarity weight: 0.81
Evidence: 0.48
Plausible(environment, be more important than economy)
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.61
¬ Plausible(pharmaceuticals, be more expensive in us)

Remarkability from sibling implausibility

0.49
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.86
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.82
Remarkable(electronics, be important to us)
Evidence: 0.66
¬ Plausible(electronics, be important to us)
0.48
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.82
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.06
Remarkable(electronics, be more expensive in europe)
Evidence: 0.05
¬ Plausible(electronics, be more expensive in europe)
0.46
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.79
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.09
Remarkable(electronics, be more expensive in uk)
Evidence: 0.07
¬ Plausible(electronics, be more expensive in uk)
0.41
Rule weight: 0.60
Evidence weight: 0.82
Similarity weight: 0.85
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.47
Remarkable(semiconductor, is expensive)
Evidence: 0.89
¬ Plausible(semiconductor, is expensive)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.65
¬ Salient(pharmaceuticals, be more expensive in us)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.97
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.72
¬ Typical(pharmaceuticals, be expensive in us)
0.61
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.97
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.69
¬ Plausible(pharmaceuticals, be expensive in us)
0.60
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.97
Evidence: 0.65
Salient(pharmaceuticals, be more expensive in us)
Evidence: 0.79
¬ Salient(pharmaceuticals, be expensive in us)
0.56
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.97
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.67
¬ Remarkable(pharmaceuticals, be expensive in us)
0.53
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.80
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.73
¬ Typical(pharmaceuticals, be expensive in states)
0.52
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.85
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.92
¬ Typical(pharmaceuticals, is expensive)
0.50
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.80
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.69
¬ Plausible(pharmaceuticals, be expensive in states)
0.50
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.85
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
0.49
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.80
Evidence: 0.65
Salient(pharmaceuticals, be more expensive in us)
Evidence: 0.79
¬ Salient(pharmaceuticals, be expensive in states)
0.48
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.85
Evidence: 0.65
Salient(pharmaceuticals, be more expensive in us)
Evidence: 0.94
¬ Salient(pharmaceuticals, is expensive)
0.47
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.85
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.87
¬ Plausible(pharmaceuticals, is expensive)
0.46
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.80
Evidence: 0.51
Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.65
¬ Remarkable(pharmaceuticals, be expensive in states)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.65
Salient(pharmaceuticals, be more expensive in us)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.73
Similarity weight: 1.00
Evidence: 0.61
Plausible(pharmaceuticals, be more expensive in us)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)

Typicality and Rermarkability incompatibility between a parent and a child

0.35
Rule weight: 0.51
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.30
¬ Typical(environment, be more important than economy)
0.27
Rule weight: 0.51
Evidence weight: 0.65
Similarity weight: 0.82
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.70
¬ Typical(industry, be significant for us)
0.26
Rule weight: 0.51
Evidence weight: 0.59
Similarity weight: 0.87
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.81
¬ Typical(industry, be important for us)
0.25
Rule weight: 0.51
Evidence weight: 0.57
Similarity weight: 0.87
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.85
¬ Typical(environment, be important for us)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.82
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.29
¬ Typical(electronics, be more expensive in europe)
0.09
Rule weight: 0.14
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.31
¬ Typical(electronics, be more expensive in uk)
0.08
Rule weight: 0.14
Evidence weight: 0.69
Similarity weight: 0.86
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.62
¬ Typical(electronics, be important to us)
0.06
Rule weight: 0.14
Evidence weight: 0.51
Similarity weight: 0.85
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
Evidence: 0.97
¬ Typical(semiconductor, is expensive)

Typicality inheritance from parent to child

0.36
Rule weight: 0.48
Evidence weight: 0.91
Similarity weight: 0.81
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.30
¬ Typical(environment, be more important than economy)
0.32
Rule weight: 0.48
Evidence weight: 0.76
Similarity weight: 0.87
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.81
¬ Typical(industry, be important for us)
0.31
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.70
¬ Typical(industry, be significant for us)
0.31
Rule weight: 0.48
Evidence weight: 0.74
Similarity weight: 0.87
Evidence: 0.70
Typical(pharmaceuticals, be more expensive in us)
Evidence: 0.85
¬ Typical(environment, be important for us)